"The risk of suicide in trials has gone down," says Arif Khan, medical director at the Northwest Clinical Research Center in Bellevue, Washington. According to him, screening out patients at risk of suicide is, perhaps unsurprisingly, leading to lower rates of suicide in clinical trials.